Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center




Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer

Head/Neck

ADU-CL-20 is an open-label, multicenter Phase 2 clinical trial to evaluate the efficacy and safety of intratumoral ADU-S100 (also referred to as MIW815) administered with pembrolizumab in the first-line setting. The population will consist of adults with PD-L1 positive recurrent or metastatic HNSCC.
Head/Neck
II
Gibson, Mike
NCT03937141
VICCHN1976

Characterization of Central Pain Syndrome in Survivors of Head and Neck Cancer

Head/Neck

This trial studies the characterization of central pain syndrome in survivors of head and neck cancer. Many head and neck cancer patients have pain after they have completed treatment. Cancer and its treatment may change how the brain manages pain. This can make treatment of post-treatment pain more challenging for health care provides. This trial is being done to better understand how the brain is responding to pain.
Head/Neck
N/A
Lou, Dianne
NCT04128267
VICCHN1982

Cancer Patient Safety Learning Laboratory (CaPSLL): Preventing Clinical Deterioration in Outpatients

Multiple Cancer Types

Head/Neck, Lung
N/A
Weinger, Matthew
VICCMD1998

Construction and Validation of an Oral Health Screening Tool in Head and Neck Cancer Survivors Who Received Chemotherapy or Radiotherapy

Multiple Cancer Types

Head/Neck, Supportive Care
N/A
Smith, Derek
VICCSUPP19107

Patient Perspectives about Discussing Financial Toxicity in Head and Neck Cancer

Head/Neck

Head/Neck
N/A
Langerman, Alexander
VICCSUPP19116

Head and Neck Tumor Tissue Repository and Clinical Database

Head/Neck

Head/Neck
N/A
Kim, Young Jun
NCT00898638
VICCHN0356

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: